A genotype-phenotype study of hereditary multiple exostoses in forty-six Chinese patients.

Authors:
Yuchan Li
Yuchan Li
Shanghai Jiaotong University School of Medicine
China
Jian Wang
Jian Wang
BGI-Shenzhen
Spartanburg | United States
Zhigang Wang
Zhigang Wang
University of Dundee
United Kingdom
Jingyan Tang
Jingyan Tang
Shanghai Jiaotong University School of Medicine
China
Tingting Yu
Tingting Yu
Shanghai Jiaotong University School of Medicine
China

BMC Med Genet 2017 11 10;18(1):126. Epub 2017 Nov 10.

Institute of Pediatric Translational Medicine, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Background: Hereditary multiple exostoses (HME) is a rare autosomal dominant skeletal disorder that can cause a variety of clinical manifestations. We aimed to evaluate the general clinical phenotypic severity of HME by using a scoring system and correlate the genotypes with different clinical phenotypes in Chinese patients.

Methods: Forty-six patients from different families were prospectively enrolled. The mutations were identified by direct sequencing of PCR-amplified genomic DNA or by multiplex ligation-dependent probe amplification (MLPA). Patients' demographic data, height, age of onset, number of anatomical sites, forearm deformity, and lower extremity alignment were analysed according to genotype and gender. A scoring system was used to assess the severity of the clinical phenotype.

Results: Thirty (60%) patients presented mutations in the EXT1 gene, and 16 (32%) presented mutations in the EXT2 gene. The mean age of onset was 2.96 years. The mean number of involved anatomic sites was 15.35. Male patients had more lesion sites than female patients (15.97 vs. 13.77, p = 0.046). The height evaluation illustrated that 67% of the patients (31 of 46) were below the 50th percentile, and the patients with EXT1 mutations were shorter than those with EXT2 mutations (p = 0.005). Forearm deformity showed a significant correlation with the number of involved anatomical sites (r = 0.382, p = 0.009). Moreover, a higher total score was found in patients with EXT1 mutations (p = 0.001).

Conclusions: The clinical manifestations of 46 Chinese HME patients were similar to those in previous reports of Western populations. Patients with EXT1 mutations have a more severe clinical phenotype than patients with EXT2 mutations.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12881-017-0488-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681804PMC
November 2017
8 Reads

Publication Analysis

Top Keywords

patients ext1
12
ext1 mutations
12
patients
11
anatomical sites
8
number involved
8
forearm deformity
8
clinical manifestations
8
ext2 mutations
8
multiple exostoses
8
scoring system
8
mutations
8
presented mutations
8
age onset
8
hereditary multiple
8
clinical
6
ext1 gene
4
mutations ext1
4
ext1
4
gene 32%
4
296 years number
4

Similar Publications

Evaluation of the anatomic burden of patients with hereditary multiple exostoses.

Clin Orthop Relat Res 2007 Sep;462:73-9

University of British Columbia, Faculty of Medicine, Division of Pediatric Orthopaedics, Department of Orthopaedics, British Columbia Children's Hospital, Vancouver, BC, Canada.

Hereditary multiple exostosis (HME) is an autosomal dominant condition resulting predominantly from mutations in the exostosin 1 (EXT1) and exostosin 2 (EXT2) genes. We asked two questions in our study: first, what is the anatomic burden of subjects with HME; second, is there a difference in anatomic burden in subjects with EXT 1 versus EXT 2. The anatomic burden experienced by HME patients was defined according to three domains: (1) lesion quality; (2) limb malalignment and deformity; and (3) limb segment lengths and percentile height. Read More

View Article
September 2007

Clinical outcome and genotype in patients with hereditary multiple exostoses.

J Orthop Res 2007 Dec;25(12):1541-51

Department of Orthopaedics, Heinrich-Heine University Hospital Duesseldorf, Moorenstr. 5, D-40225 Duesseldorf, Germany.

Hereditary multiple exostoses (HME) is an autosomal dominant skeletal disorder with a wide spectrum of clinical manifestations. In 52 out of 60 individuals from HME+ families, exostoses became clinically apparent. In this study, the clinical and radiological outcome of these 52 HME patients (19 families) was investigated by medical history, clinical examination, and radiographs. Read More

View Article
December 2007

Genotype-phenotype correlation study in 529 patients with multiple hereditary exostoses: identification of "protective" and "risk" factors.

J Bone Joint Surg Am 2011 Dec;93(24):2294-302

Department of Medical Genetics and Skeletal Rare Diseases, Rizzoli Orthopaedic Institute, Bologna, Italy.

Background: Multiple hereditary exostoses is an autosomal dominant skeletal disorder characterized by wide variation in clinical phenotype. The aim of this study was to evaluate whether the severity of the disease is linked with a specific genetic background.

Methods: Five hundred and twenty-nine patients with multiple hereditary exostoses from two different European referral centers participated in the study. Read More

View Article
December 2011

[A splicing mutation of EXT1 in a Chinese pedigree with hereditary multiple exostoses].

Zhongguo Dang Dai Er Ke Za Zhi 2014 Feb;16(2):174-80

Department of Peadiatrics, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100005, China.

Objective: Hereditary multiple exostoses (HME) is an autosomal dominant monogenic disorder of paraplasia ossium. Mutations in EXT1 and EXT2 have been suggested to be responsible for over 70% of HME cases. This study aimed to analyze the clinical features and pathogenic mutations in a Chinese family with HME (6 patients in 24 members of 3 generations) and to review the relative literature regarding mutations in EXT1 and EXT2 in the Chinese population. Read More

View Article
February 2014